To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)

NCT00398151 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK0476, montelukast sodium / Duration of Treatment: 12 Weeks

Sponsor

Organon and Co